Literature DB >> 12604545

Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila.

Raymond P Smith1, Aldona L Baltch, Phyllis B Michelsen, William J Ritz, Richard Alteri.   

Abstract

Using the standard Craig and Gudmundsson method (W. A. Craig and S. Gudmundsson, p. 296-329, in V. Lorian, ed., Antibiotics in Laboratory Medicine, 1996) as a guideline for determination of postantibiotic effects (PAE), we studied a large series of growth curves for two strains of Legionella pneumophila. We found that the intensity of the PAE was best determined by using a statistically fitted line over hours 3 to 9 following antibiotic removal. We further determined the PAE duration by using a series of observations of the assay interval from hours 3 to 24. We determined that inoculum reduction was not necessarily the only predictor of the PAE but that the PAE was subject to the type and dose of the drug used in the study. In addition, there was a variation between strains. Only levofloxacin at five and ten times the minimum inhibitory concentration (MIC) resulted in a PAE duration of 4 to 10 h for both strains of L. pneumophila tested. Ciprofloxacin at five and ten times the MIC and azithromycin at ten times the MIC caused a PAE for one strain only. No PAE could be demonstrated for either strain with erythromycin or doxycycline. Using the presently described method of measuring PAE for L. pneumophila, we were able to detect differences in PAE which were dependent upon the L. pneumophila strain, the antibiotic tested, and the antibiotic concentration. We suggest the use of mathematically fitted curves for comparison of bacterial growth in order to measure PAE for L. pneumophila.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604545      PMCID: PMC149292          DOI: 10.1128/AAC.47.3.1081-1087.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  The postantibiotic effect: a review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  DICP       Date:  1991-02

2.  THE RECOVERY OF BACTERIA FROM THE TOXIC EFFECTS OF PENICILLIN.

Authors:  H Eagle
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

3.  Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila.

Authors:  S J Martin; S L Pendland
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

4.  Postantibiotic effects.

Authors:  B S Vogelman; W A Craig
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

5.  Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

Authors:  R Gómez-Lus; F Adrián; R del Campo; P Gómez-Lus; S Sánchez; C García; M C Rubio
Journal:  Int J Antimicrob Agents       Date:  2001-07       Impact factor: 5.283

6.  Automatic procedures for measuring post-antibiotic effect and determining random errors.

Authors:  A C Jason; F M MacKenzie; D Jason; I M Gould
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

7.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

Review 8.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

9.  Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.

Authors:  R P Smith; A L Baltch; M Franke; W Hioe; W Ritz; P Michelsen
Journal:  J Antimicrob Chemother       Date:  1997-11       Impact factor: 5.790

10.  Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.

Authors:  P H Edelstein; M A Edelstein; J Ren; R Polzer; R P Gladue
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more
  3 in total

1.  Temperature-Dependent Growth Modeling of Environmental and Clinical Legionella pneumophila Multilocus Variable-Number Tandem-Repeat Analysis (MLVA) Genotypes.

Authors:  Yehonatan Sharaby; Sarah Rodríguez-Martínez; Olga Oks; Marina Pecellin; Hila Mizrahi; Avi Peretz; Ingrid Brettar; Manfred G Höfle; Malka Halpern
Journal:  Appl Environ Microbiol       Date:  2017-03-31       Impact factor: 4.792

2.  Characterization of the anti-Staphylococcus aureus fraction from Penthorum chinense Pursh stems.

Authors:  Bin Ding; Qinchao Ding; Shun Zhang; Zhuo Jin; Zhaolei Wang; Songtao Li; Xiaobing Dou
Journal:  BMC Complement Altern Med       Date:  2019-08-17       Impact factor: 3.659

3.  Phage-mimicking antibacterial core-shell nanoparticles.

Authors:  Juliane Hopf; Margo Waters; Veronica Kalwajtys; Katelyn E Carothers; Ryan K Roeder; Joshua D Shrout; Shaun W Lee; Prakash D Nallathamby
Journal:  Nanoscale Adv       Date:  2019-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.